Review article · 2016 · Open access
Screening applications in drug discovery based on microfluidic technology
Biomicrofluidics, 10(1), 011502 · Published 1 January 2016 · DOI 10.1063/1.4940886
In brief
“Screening applications in drug discovery based on microfluidic technology” is a 2016 review article by Pınar Eribol and 2 co-authors, published in Biomicrofluidics. OpenAlex counts 52 citations as of 19 November 2026. It is open access: the full text is free to read at Biomicrofluidics.
- Citations
- 52
- Most cited in
- 2017 (9)
- Field-weighted impact
- 0.62
- References
- 113
- Authors
- 3
Abstract
Microfluidics has been the focus of interest for the last two decades for all the advantages such as low chemical consumption, reduced analysis time, high throughput, better control of mass and heat transfer, downsizing a bench-top laboratory to a chip, i.e., lab-on-a-chip, and many others it has offered. Microfluidic technology quickly found applications in the pharmaceutical industry, which demands working with leading edge scientific and technological breakthroughs, as drug screening and commercialization are very long and expensive processes and require many tests due to unpredictable results. This review paper is on drug candidate screening methods with microfluidic technology and focuses specifically on fabrication techniques and materials for the microchip, types of flow such as continuous or discrete and their advantages, determination of kinetic parameters and their comparison with conventional systems, assessment of toxicities and cytotoxicities, concentration generations for high throughput, and the computational methods that were employed. An important conclusion of this review is that even though microfluidic technology has been in this field for around 20 years there is still room for research and development, as this cutting edge technology requires ingenuity to design and find solutions for each individual case. Recent extensions of these microsystems are microengineered organs-on-chips and organ arrays.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Eribol, P., Uğuz, A. K., & Ülgen, K. Ö. (2016). Screening applications in drug discovery based on microfluidic technology. Biomicrofluidics, 10(1), 011502. https://doi.org/10.1063/1.4940886
MLA 9
Eribol, Pınar, et al. “Screening applications in drug discovery based on microfluidic technology.” Biomicrofluidics, vol. 10, no. 1, 2016, p. 011502. https://doi.org/10.1063/1.4940886.
Chicago
Eribol, Pınar, A. Kerem Uğuz, and Kutlu Ö. Ülgen. 2016. “Screening applications in drug discovery based on microfluidic technology.” Biomicrofluidics 10 (1): 011502. https://doi.org/10.1063/1.4940886.
Harvard
Eribol, P., Uğuz, A. K. and Ülgen, K. Ö. (2016) ‘Screening applications in drug discovery based on microfluidic technology’, Biomicrofluidics, 10(1), p. 011502. doi:10.1063/1.4940886.
IEEE
P. Eribol, A. K. Uğuz, and K. Ö. Ülgen, “Screening applications in drug discovery based on microfluidic technology,” Biomicrofluidics, vol. 10, no. 1, p. 011502, 2016, doi: 10.1063/1.4940886.
BibTeX
@article{eribol2016screening,
title = {{Screening applications in drug discovery based on microfluidic technology}},
author = {Eribol, Pınar and Uğuz, A. Kerem and Ülgen, Kutlu Ö.},
journal = {Biomicrofluidics},
year = {2016},
volume = {10},
number = {1},
pages = {011502},
doi = {10.1063/1.4940886},
url = {https://doi.org/10.1063/1.4940886}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 9 | |
| 2018 | 6 | |
| 2019 | 5 | |
| 2020 | 6 | |
| 2021 | 4 | |
| 2022 | 1 | |
| 2023 | 4 | |
| 2024 | 3 | |
| 2025 | 2 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.62: it has been cited 0.62 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- microfluidics
- drug screening
- lab-on-a-chip
- microchip fabrication
- continuous flow
- discrete flows
- kinetic parameters
- cytotoxicity
Work with this paper
Most-cited papers in Engineering
- A Closed‐form Equation for Predicting the Hydraulic Conductivity of Unsaturated SoilsMartinus Th. van Genuchten · Soil Science Society of America Journal · 1980 · 28,197 citations
- An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experimentsW. C. Oliver, George M. Pharr · Journal of materials research/Pratt's guide to venture capital sources · 1992 · 27,379 citations
- Digital communicationsOwen Bishop · Routledge eBooks · 2007 · 24,890 citations
- The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysisNorden Eh Huang, Zhengwei Shen, Steven R. Long and 6 more · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · 1998 · 24,008 citations
- Numerical Heat Transfer and Fluid FlowSuhas V. Patankar · CRC Press eBooks · 2018 · 23,491 citations
Questions about this paper
How do I cite this paper in APA style?
Eribol, P., Uğuz, A. K., & Ülgen, K. Ö. (2016). Screening applications in drug discovery based on microfluidic technology. Biomicrofluidics, 10(1), 011502. https://doi.org/10.1063/1.4940886
How many times has this paper been cited?
52 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Biomicrofluidics: sign in and open the PDF from this page.
Who wrote this paper?
Pınar Eribol, A. Kerem Uğuz, Kutlu Ö. Ülgen.
What is the DOI of this paper?
10.1063/1.4940886, permanently at https://doi.org/10.1063/1.4940886. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.